<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2018-06-14" updated="2019-12-02">
  <drugbank-id primary="true">DB14058</drugbank-id>
  <name>Basifungin</name>
  <description>Basifungin, also known as _aureuobacidin A_, is a phosphorylceramide synthase inhibitor [L2960], [A33381].</description>
  <cas-number>127785-64-2</cas-number>
  <unii>VV0USO6I6U</unii>
  <average-mass>1085.442</average-mass>
  <monoisotopic-mass>1084.693641194</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A33381</ref-id>
        <pubmed-id>19047657</pubmed-id>
        <citation>Aeed PA, Young CL, Nagiec MM, Elhammer AP: Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. Antimicrob Agents Chemother. 2009 Feb;53(2):496-504. doi: 10.1128/AAC.00633-08. Epub 2008 Dec 1.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2959</ref-id>
        <title>Basifungin</title>
        <url>https://adisinsight.springer.com/drugs/800004447</url>
      </link>
      <link>
        <ref-id>L2960</ref-id>
        <title>AUR1- Uniprot</title>
        <url>http://www.uniprot.org/uniprot/O13332</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Aureobasidin A</synonym>
    <synonym language="english" coder="inn">Basifungin</synonym>
  </synonyms>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antifungal Agents</category>
      <mesh-id>D000935</mesh-id>
    </category>
    <category>
      <category>Enzyme Inhibitors</category>
      <mesh-id>D004791</mesh-id>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
    <category>
      <category>Peptides, Cyclic</category>
      <mesh-id>D010456</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00266</drugbank-id>
      <name>Dicoumarol</name>
      <description>The therapeutic efficacy of Dicoumarol can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00498</drugbank-id>
      <name>Phenindione</name>
      <description>The therapeutic efficacy of Phenindione can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00682</drugbank-id>
      <name>Warfarin</name>
      <description>The therapeutic efficacy of Warfarin can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00946</drugbank-id>
      <name>Phenprocoumon</name>
      <description>The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01418</drugbank-id>
      <name>Acenocoumarol</name>
      <description>The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03410</drugbank-id>
      <name>4-hydroxycoumarin</name>
      <description>The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04665</drugbank-id>
      <name>Coumarin</name>
      <description>The therapeutic efficacy of Coumarin can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08496</drugbank-id>
      <name>(R)-warfarin</name>
      <description>The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08794</drugbank-id>
      <name>Ethyl biscoumacetate</name>
      <description>The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13136</drugbank-id>
      <name>Fluindione</name>
      <description>The therapeutic efficacy of Fluindione can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13275</drugbank-id>
      <name>Clorindione</name>
      <description>The therapeutic efficacy of Clorindione can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13347</drugbank-id>
      <name>Diphenadione</name>
      <description>The therapeutic efficacy of Diphenadione can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13451</drugbank-id>
      <name>Tioclomarol</name>
      <description>The therapeutic efficacy of Tioclomarol can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14055</drugbank-id>
      <name>(S)-Warfarin</name>
      <description>The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Basifungin.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>5.14</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-5.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>3.95e-03 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>7.02</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(3R,6S,9S,12S,15S,21S,24S,29aS)-21,24-dibenzyl-15-[(2R)-butan-2-yl]-5,11,23-trimethyl-3-[(2R)-3-methylbutan-2-yl]-9-(2-methylpropyl)-6,12,18-tris(propan-2-yl)-octacosahydropyrrolo[1,2-m]1-oxa-4,7,10,13,16,19,22,25-octaazacycloheptacosane-1,4,7,10,13,16,19,22,25-nonone</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>aureobasidin A</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>1085.442</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>1084.693641194</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC[C@@H](C)[C@@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C(NC1=O)C(C)C)[C@H](C)C(C)C</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C60H92N8O10</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C60H92N8O10/c1-17-39(12)51-55(72)63-47(36(6)7)53(70)61-44(32-41-25-20-18-21-26-41)56(73)65(14)46(33-42-27-22-19-23-28-42)58(75)68-30-24-29-45(68)52(69)64-48(40(13)35(4)5)59(76)66(15)49(37(8)9)54(71)62-43(31-34(2)3)57(74)67(16)50(38(10)11)60(77)78-51/h18-23,25-28,34-40,43-51H,17,24,29-33H2,1-16H3,(H,61,70)(H,62,71)(H,63,72)(H,64,69)/t39-,40-,43+,44+,45+,46+,47?,48-,49+,50+,51+/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>YHSKJPXGXIYLHB-OTNPUQRPSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>223.94</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>297.75</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>118</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>13</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>11.76</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-2.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>61739</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>26332345</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0009553</id>
      <name>Inositol phosphorylceramide synthase</name>
      <organism>Yeast</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A33381</ref-id>
            <pubmed-id>19047657</pubmed-id>
            <citation>Aeed PA, Young CL, Nagiec MM, Elhammer AP: Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. Antimicrob Agents Chemother. 2009 Feb;53(2):496-504. doi: 10.1128/AAC.00633-08. Epub 2008 Dec 1.</citation>
          </article>
        </articles>
        <textbooks/>
        <links>
          <link>
            <ref-id>L2968</ref-id>
            <title>aureobasidin A ( Basifungin)</title>
            <url>https://www.semanticscholar.org/topic/aureobasidin-A/853115</url>
          </link>
          <link>
            <ref-id>L2969</ref-id>
            <title>Basifungin PubChem</title>
            <url>https://pubchem.ncbi.nlm.nih.gov/compound/9919816#section=Top</url>
          </link>
        </links>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="O13332" source="Swiss-Prot">
        <name>Inositol phosphorylceramide synthase</name>
        <general-function>Catalyzes the addition of a phosphorylinositol group onto ceramide to form inositol phosphorylceramide, an essential step in sphingolipid biosynthesis.</general-function>
        <specific-function>Inositol phosphoceramide synthase activity</specific-function>
        <gene-name>AUR1</gene-name>
        <locus/>
        <cellular-location>Golgi apparatus</cellular-location>
        <transmembrane-regions>55-75
78-98
101-121
169-189
192-212
259-279
282-302
305-325</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>53457.9</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="237561">Yeast</organism>
        <external-identifiers>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O13332</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>AUR1_CANAL</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.-.-.-</synonym>
          <synonym>Aureobasidin A resistance protein homolog</synonym>
          <synonym>IPC synthase</synonym>
          <synonym>Phosphatidylinositol:ceramide phosphoinositol transferase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0051975|Inositol phosphorylceramide synthase
MASSILRSKIIQKPYQLFHYYFLSEKAPGSTVSDLNFDTNIQTSLRKLKHHHWTVGEIFH
YGFLVSILFFVFVVFPASFFIKLPIILAFATCFLIPLTSQFFLPALPVFTWLALYFTCAK
IPQEWKPAITVKVLPAMETILYGDNLSNVLATITTGVLDILAWLPYGIIHFSFPFVLAAI
IFLFGPPTALRSFGFAFGYMNLLGVLIQMAFPAAPPWYKNLHGLEPANYSMHGSPGGLGR
IDKLLGVDMYTTGFSNSSIIFGAFPSLHSGCCIMEVLFLCWLFPRFKFVWVTYASWLWWS
TMYLTHHYFVDLIGGAMLSLTVFEFTKYKYLPKNKEGLFCRWSYTEIEKIDIQEIDPLSY
NYIPINSNDNESRLYTRVYQESQVSPPSRAETPEAFEMSNFSRSRQSSKTQVPLSNLTNN
DQVPGINEEDEEEEGDEISSSTPSVFEDEPQGSTYAASSATSVDDLDSKRN</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0051976|Inositol phosphorylceramide synthase (AUR1)
ATGGCATCTTCTATTTTGCGTTCCAAAATAATACAAAAACCGTACCAATTATTCCACTAC
TATTTTCTTCTGGAGAAGGCTCCTGGTTCTACAGTTAGTGATTTGAATTTTGATACAAAC
ATACAAACGAGTTTACGTAAATTAAAGCATCATCATTGGACGGTGGGAGAAATATTCCAT
TATGGGTTTTTGGTTTCCATACTTTTTTTCGTGTTTGTGGTTTTCCCAGCTTCATTTTTT
ATAAAATTACCAATAATCTTAGCATTTGCTACTTGTTTTTTAATACCCTTAACATCACAA
TTTTTTCTTCCTGCCTTGCCCGTTTTCACTTGGTTGGCATTATATTTTACGTGTGCTAAA
ATACCTCAAGAATGGAAACCAGCTATCACAGTTAAAGTTTTACCAGCTATGGAAACAATT
TTGTACGGCGATAATTTATCAAATGTTTTGGCAACCATCACTACCGGAGTGTTAGATATA
TTGGCATGGTTACCATATGGGATTATTCATTTCAGTTTCCCATTTGTACTTGCTGCTATT
ATATTTTTATTTGGGCCACCGACGGCATTAAGATCATTTGGGTTTGCCTTTGGTTATATG
AACTTGCTTGGAGTCTTGATTCAAATGGCATTCCCAGCTGCTCCTCCATGGTACAAAAAC
TTGCACGGATTAGAACCAGCTAATTATTCAATGCACGGGTCTCCTGGTGGACTTGGAAGG
ATAGATAAATTGTTAGGTGTTGATATGTATACCACCGGATTTTCCAATTCATCAATCATT
TTTGGGGCATTCCCATCGTTACATTCAGGATGTTGTATCATGGAAGTGTTATTTTTGTGT
TGGTTGTTTCCACGATTCAAGTTTGTGTGGGTTACATACGCATCTTGGCTTTGGTGGAGC
ACGATGTATTTGACTCATCACTACTTTGTCGATTTGATTGGTGGAGCCATGTTATCTTTG
ACTGTTTTTGAATTCACTAAATATAAATATTTGCCAAAAAACAAAGAAGGCCTTTTCTGT
CGTTGGTCATACACTGAAATTGAAAAAATCGATATCCAAGAAATTGACCCTTTATCATAC
AATTATATCCCTATCAACAGCAATGATAATGAAAGCAGATTGTATACGAGAGTGTACCAA
GAGTCTCAGGTTAGTCCCCCACTGAGAGCTGAAACACCTGAAGCATTTGAGATGTCAAAT
TTTTCTAGGTCCAGACAAAGCTCAAAGACTCAGGTTCCATTGAGTAATCTTACTAACAAT
GATCAAGTGCCTGGAATTAACGAAGAGGATGAAGAAGAAGAAGGCGATGAAATTTCGTCG
AGTACTCCTTCGGTGTTTGAAGACGAACCACAGGGTAGCACATATGCTGCATCCTCAGCT
ACATCAGTAGATGATTTGGATTCCAAAAGAAATTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF14378</identifier>
            <name>PAP2_3</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>Golgi cisterna membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>inositol phosphoceramide synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to drug</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sphingolipid metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>